Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature

  • PDF / 744,778 Bytes
  • 22 Pages / 595.276 x 790.866 pts Page_size
  • 63 Downloads / 196 Views

DOWNLOAD

REPORT


ORIGINAL PAPER

Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature Klas Kellerborg1   · Werner Brouwer1 · Pieter van Baal1 Received: 14 June 2019 / Accepted: 3 July 2020 © The Author(s) 2020

Abstract Pandemics and major outbreaks have the potential to cause large health losses and major economic costs. To prioritize between preventive and responsive interventions, it is important to understand the costs and health losses interventions may prevent. We review the literature, investigating the type of studies performed, the costs and benefits included, and the methods employed against perceived major outbreak threats. We searched PubMed and SCOPUS for studies concerning the outbreaks of SARS in 2003, H5N1 in 2003, H1N1 in 2009, Cholera in Haiti in 2010, MERS-CoV in 2013, H7N9 in 2013, and Ebola in West-Africa in 2014. We screened titles and abstracts of papers, and subsequently examined remaining full-text papers. Data were extracted according to a pre-constructed protocol. We included 34 studies of which the majority evaluated interventions related to the H1N1 outbreak in a high-income setting. Most interventions concerned pharmaceuticals. Included costs and benefits, as well as the methods applied, varied substantially between studies. Most studies used a short time horizon and did not include future costs and benefits. We found substantial variation in the included elements and methods used. Policymakers need to be aware of this and the bias toward high-income countries and pharmaceutical interventions, which hampers generalizability. More standardization of included elements, methodology, and reporting would improve economic evaluations and their usefulness for policy. Keywords  Literature review · Health economics · Economic evaluations · Infectious diseases · Future costs JEL Classification  I190 · I180

Introduction Historically, infectious disease outbreaks have proven to be potentially devastating. A prominent example is the Spanish influenza which may have claimed as many as 50 million lives [1]. The number of outbreaks of infectious diseases has been increasing since 1980, as has the number of unique pathogens [2]. To prevent and effectively combat outbreaks, reporting agreements such as those arranged in the International Health Regulations (IHR) between national governments and international organizations were established [3]. Electronic supplementary material  The online version of this article (https​://doi.org/10.1007/s1019​8-020-01218​-4) contains supplementary material, which is available to authorized users. * Klas Kellerborg [email protected] 1



Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands

The current IHR require the countries which ratified them to develop a minimum capacity of core functions related to surveillance and response [3]. However, with new threats emerging and given the fragile health systems in many parts of the world, outbreaks still have the potential to occ